Literature DB >> 7433342

Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.

J E Carlsen, J Trap-Jensen, T L Svendsen, P E Nielsen, S Rasmussen, N J Christensen.   

Abstract

Mean arterial blood pressure was decreased by intravenous labetalol in 14 hypertensive patients, resting in the supine position, when standing, during exercise and during psychic stress. Heart rate was unchanged during psychic stress and while resting in the supine position, whereas it fell in the other situations. Plasma noradrenaline increased in all situations after labetalol compared to control studies. Plasma adrenaline only increased when standing and during stress, and there was no correlation between changes in plasma noradrenaline and adrenaline. Blood glucose rose significantly after labetalol in the supine position, whereas it only tended to increase in the other experimental situations. The changes in plasma noradrenaline and blood glucose induced by labetalol are identical to those seen after pure alpha-adrenoceptor blockade. The beta-adrenoceptor blocking property of labetalol may contribute to the higher plasma concentration of noradrenaline when standing and during exercise as this has been found during pure beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7433342

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

2.  Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.

Authors:  J Trap-Jensen; J E Carlsen; O J Hartling; T L Svendsen; M Tangø; N J Christensen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 3.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 4.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.